Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-04-01 Sale | 2025-04-02 4:12 pm | Amneal Pharmaceuticals Inc. | AMRX | Patel Gautam Director | 80,000 | $8.3 | $664,000 | 1,728,886 (Direct) | View |
| 2025-03-14 Sale | 2025-03-17 4:51 pm | Amneal Pharmaceuticals Inc. | AMRX | Patel Tushar Bhikhubhai 10% Owner | 5,000,000 | $8.35 | $41,750,000 | 48,578,209 (Indirect) | View |
| 2025-03-05 Sale | 2025-03-07 4:18 pm | Amneal Pharmaceuticals Inc. | AMRX | BOYER ANDREW S Executive Vice President | 125,000 | $8.89 | $1,111,250 | 290,106 (Direct) | View |
| 2025-03-05 Sale | 2025-03-07 4:17 pm | Amneal Pharmaceuticals Inc. | AMRX | Daly Jason B. EVP, Chief Legal Officer | 90,000 | $8.8018 | $792,160 | 32,606 (Direct) | View |
| 2025-03-05 Sale | 2025-03-07 4:17 pm | Amneal Pharmaceuticals Inc. | AMRX | Konidaris Tasos Executive Vice President & CFO | 100,000 | $8.91 | $891,000 | 621,882 (Direct) | View |
| 2025-03-05 Sale | 2025-03-07 4:16 pm | Amneal Pharmaceuticals Inc. | AMRX | Alva Emily Peterson Director | 80,000 | $8.9 | $712,000 | 170,771 (Direct) | View |
| 2025-03-03 Sale | 2025-03-05 7:12 pm | Amneal Pharmaceuticals Inc. | AMRX | Patel Gautam Director | 80,000 | $8.9 | $712,000 | 1,808,886 (Direct) | View |
| 2025-02-03 Sale | 2025-02-05 4:31 pm | Amneal Pharmaceuticals Inc. | AMRX | Patel Gautam Director | 80,000 | $8.14 | $651,200 | 1,888,886 (Direct) | View |
| 2025-01-08 Sale | 2025-01-10 4:25 pm | Amneal Pharmaceuticals Inc. | AMRX | Patel Gautam Director | 62,590 | $8.01 | $501,346 | 1,968,886 (Direct) | View |
| 2025-01-02 Sale | 2025-01-06 4:22 pm | Amneal Pharmaceuticals Inc. | AMRX | Patel Gautam Director | 17,410 | $8.01 | $139,454 | 2,031,476 (Direct) | View |
| 2024-11-22 Sale | 2024-11-26 4:41 pm | Amneal Pharmaceuticals Inc. | AMRX | Kiely John Director | 17,058 | $8.38 | $142,946 | 267,175 (Direct) | View |
| 2024-11-21 Sale | 2024-11-25 4:26 pm | Amneal Pharmaceuticals Inc. | AMRX | Autor Deborah M. Director | 40,000 | $8.3518 | $334,074 | 53,402 (Direct) | View |
| 2024-11-21 Sale | 2024-11-22 4:38 pm | Amneal Pharmaceuticals Inc. | AMRX | Daly Jason B. SVP, Chief Legal Officer | 13,665 | $8.4 | $114,786 | 0 (Direct) | View |
| 2024-11-15 Sale | 2024-11-19 4:17 pm | Amneal Pharmaceuticals Inc. | AMRX | Daly Jason B. SVP, Chief Legal Officer | 43,657 | $8.61 | $375,887 | 13,665 (Direct) | View |
| 2024-08-14 Sale | 2024-08-16 4:18 pm | Amneal Pharmaceuticals Inc. | AMRX | BOYER ANDREW S Executive Vice President | 62,711 | $7.8357 | $491,382 | 256,670 (Direct) | View |
| 2024-08-14 Sale | 2024-08-16 4:17 pm | Amneal Pharmaceuticals Inc. | AMRX | Shah Nikita Executive Vice President | 100,000 | $7.75 | $775,000 | 291,666 (Direct) | View |
| 2024-05-16 Sale | 2024-05-20 4:10 pm | Amneal Pharmaceuticals Inc. | AMRX | Autor Deborah M. Director | 38,000 | $6.7396 | $256,106 | 93,402 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-03-10 Gift | 2025-03-12 4:11 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | BUCHI J KEVIN Director | 262,072 | $0 | 262,072 (Direct) | View |
| 2025-03-03 Tax Withholding | 2025-03-05 8:21 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Daly Jason B. EVP, Chief Legal Officer | 49,145 | $8.76 | 620,440 (Direct) | View |
| 2025-03-04 Tax Withholding | 2025-03-05 8:21 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Daly Jason B. EVP, Chief Legal Officer | 15,579 | $8.84 | 620,440 (Direct) | View |
| 2025-03-03 Option Award | 2025-03-05 8:21 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Daly Jason B. EVP, Chief Legal Officer | 291,096 | $0 | 620,440 (Direct) | View |
| 2025-03-03 Exercise | 2025-03-05 8:21 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Daly Jason B. EVP, Chief Legal Officer | 187,330 | $0 | 620,440 (Direct) | View |
| 2025-03-03 Tax Withholding | 2025-03-05 8:18 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | BOYER ANDREW S Executive Vice President | 125,805 | $8.76 | 959,426 (Direct) | View |
| 2025-03-04 Tax Withholding | 2025-03-05 8:18 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | BOYER ANDREW S Executive Vice President | 19,537 | $8.84 | 959,426 (Direct) | View |
| 2025-03-03 Option Award | 2025-03-05 8:18 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | BOYER ANDREW S Executive Vice President | 291,096 | $0 | 959,426 (Direct) | View |
| 2025-03-03 Exercise | 2025-03-05 8:18 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | BOYER ANDREW S Executive Vice President | 284,144 | $0 | 959,426 (Direct) | View |
| 2025-03-03 Tax Withholding | 2025-03-05 7:53 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Konidaris Tasos Executive Vice President & CFO | 133,410 | $8.76 | 1,356,260 (Direct) | View |
| 2025-03-04 Tax Withholding | 2025-03-05 7:53 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Konidaris Tasos Executive Vice President & CFO | 22,497 | $8.84 | 1,356,260 (Direct) | View |
| 2025-03-03 Option Award | 2025-03-05 7:53 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Konidaris Tasos Executive Vice President & CFO | 342,465 | $0 | 1,356,260 (Direct) | View |
| 2025-03-03 Exercise | 2025-03-05 7:53 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Konidaris Tasos Executive Vice President & CFO | 327,770 | $0 | 1,356,260 (Direct) | View |
| 2025-03-03 Tax Withholding | 2025-03-05 7:33 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Patel Chirag K. President & Co-CEO | 279,527 | $8.76 | 23,535,314 (Direct) | View |
| 2025-03-04 Tax Withholding | 2025-03-05 7:33 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Patel Chirag K. President & Co-CEO | 47,361 | $8.84 | 23,535,314 (Direct) | View |
| 2025-03-03 Option Award | 2025-03-05 7:33 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Patel Chirag K. President & Co-CEO | 1,130,136 | $0 | 23,535,314 (Direct) | View |
| 2025-03-03 Exercise | 2025-03-05 7:33 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Patel Chirag K. President & Co-CEO | 672,302 | $0 | 23,535,314 (Direct) | View |
| 2025-03-03 Tax Withholding | 2025-03-05 7:31 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Patel Chintu Co-CEO | 274,307 | $8.76 | 27,025,199 (Direct) | View |
| 2025-03-04 Tax Withholding | 2025-03-05 7:31 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Patel Chintu Co-CEO | 46,528 | $8.84 | 27,025,199 (Direct) | View |
| 2025-03-03 Option Award | 2025-03-05 7:31 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Patel Chintu Co-CEO | 1,130,136 | $0 | 27,025,199 (Direct) | View |
| 2025-03-03 Exercise | 2025-03-05 7:31 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Patel Chintu Co-CEO | 672,302 | $0 | 27,025,199 (Direct) | View |
| 2025-03-03 Tax Withholding | 2025-03-05 7:11 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Shah Nikita Executive Vice President | 116,128 | $8.76 | 956,218 (Direct) | View |
| 2025-03-04 Tax Withholding | 2025-03-05 7:11 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Shah Nikita Executive Vice President | 18,353 | $8.84 | 956,218 (Direct) | View |
| 2025-03-03 Option Award | 2025-03-05 7:11 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Shah Nikita Executive Vice President | 282,534 | $0 | 956,218 (Direct) | View |
| 2025-03-03 Exercise | 2025-03-05 7:11 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Shah Nikita Executive Vice President | 262,911 | $0 | 956,218 (Direct) | View |
| 2025-03-01 Tax Withholding | 2025-03-04 7:03 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | BOYER ANDREW S Executive Vice President | 11,737 | $8.67 | 276,304 (Direct) | View |
| 2025-03-01 Exercise | 2025-03-04 7:03 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | BOYER ANDREW S Executive Vice President | 31,371 | $0 | 276,304 (Direct) | View |
| 2025-03-01 Tax Withholding | 2025-03-04 6:59 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Konidaris Tasos Executive Vice President & CFO | 13,494 | $8.67 | 550,019 (Direct) | View |
| 2025-03-01 Exercise | 2025-03-04 6:59 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Konidaris Tasos Executive Vice President & CFO | 36,197 | $0 | 550,019 (Direct) | View |
| 2025-03-01 Tax Withholding | 2025-03-04 6:58 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Shah Nikita Executive Vice President | 10,985 | $8.67 | 309,639 (Direct) | View |
| 2025-03-01 Exercise | 2025-03-04 6:58 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Shah Nikita Executive Vice President | 28,958 | $0 | 309,639 (Direct) | View |
| 2024-11-22 Exercise | 2024-11-26 4:41 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Kiely John Director | 28,506 | $4.76 | 267,175 (Direct) | View |
| 2024-11-22 Exercise | 2024-11-26 4:41 pm | N/A 2029-12-14 | Amneal Pharmaceuticals Inc. | AMRX | Kiely John Director | 28,506 | $0 | 267,175 (Direct) | View |
| 2024-05-10 Exercise | 2024-05-14 4:45 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Alva Emily Peterson Director | 76,453 | $0 | 250,771 (Direct) | View |
| 2024-05-10 Exercise | 2024-05-14 4:45 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Autor Deborah M. Director | 76,453 | $0 | 131,402 (Direct) | View |
| 2024-05-10 Exercise | 2024-05-14 4:44 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | MEISTER PAUL M Director | 107,034 | $0 | 727,692 (Direct) | View |
| 2024-05-10 Exercise | 2024-05-14 4:43 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Kiely John Director | 76,453 | $0 | 255,727 (Direct) | View |
| 2024-05-10 Exercise | 2024-05-14 4:42 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | George Jeffrey P. Director | 76,453 | $0 | 269,537 (Direct) | View |
| 2024-05-10 Exercise | 2024-05-14 4:41 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | BUCHI J KEVIN Director | 76,453 | $0 | 262,072 (Direct) | View |
| 2024-05-10 Exercise | 2024-05-14 4:40 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Nark Ted C Director | 76,453 | $0 | 300,771 (Direct) | View |
| 2024-05-10 Exercise | 2024-05-14 4:39 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Yanai Shlomo Director | 76,453 | $0 | 245,727 (Direct) | View |
| 2024-05-10 Exercise | 2024-05-14 4:38 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Patel Gautam Director | 76,453 | $0 | 2,048,886 (Direct) | View |
| 2024-05-02 Option Award | 2024-05-06 5:38 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Yanai Shlomo Director | 40,258 | $0 | 40,258 (Direct) | View |
| 2024-05-02 Option Award | 2024-05-06 5:35 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Patel Gautam Director | 40,258 | $0 | 40,258 (Direct) | View |
| 2024-05-02 Option Award | 2024-05-06 5:34 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Nark Ted C Director | 40,258 | $0 | 40,258 (Direct) | View |
| 2024-05-02 Option Award | 2024-05-06 5:31 pm | N/A N/A | Amneal Pharmaceuticals Inc. | AMRX | Kiely John Director | 40,258 | $0 | 40,258 (Direct) | View |